Vertex Pharmaceuticals
VRTX
$467.28
Share price
-1.35%
Change (1 day)
36.36%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $5.37 B
According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are $5.37 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $5.14 B | 21.51% |
| 2022-12-31 | $4.23 B | 27.18% |
| 2021-12-31 | $3.33 B | 8.73% |
| 2020-12-31 | $3.06 B | 37.25% |
| 2019-12-31 | $2.23 B | 23.34% |
| 2018-12-31 | $1.81 B | 20.42% |
| 2017-12-31 | $1.50 B | -3.52% |
| 2016-12-31 | $1.55 B | 10.94% |
| 2015-12-31 | $1.40 B | 13.44% |
| 2014-12-31 | $1.23 B | 28.66% |
| 2013-12-31 | $0.96 B | -38.43% |
| 2012-12-31 | $1.56 B | 22.55% |
| 2011-12-31 | $1.27 B | 4.45% |
| 2010-12-31 | $1.22 B | 42.17% |
| 2009-12-31 | $0.85 B | 15.85% |
| 2008-12-31 | $0.74 B | 124.6% |
| 2007-12-31 | $0.33 B | -20.56% |
| 2006-12-31 | $0.41 B | 34.16% |
| 2005-12-31 | $0.30 B | -39.25% |
| 2004-12-31 | $0.51 B | -4.05% |
| 2003-12-31 | $0.53 B | 21.6% |
| 2002-12-31 | $0.43 B | -2.81% |
| 2001-12-31 | $0.44 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 1,798.15% | 🇺🇸 USA |
 AbbVie ABBV | $140.82 B | 2,522.09% | 🇺🇸 USA |
 Gilead Sciences GILD | $38.83 B | 623.11% | 🇺🇸 USA |
 Merck MRK | $65.42 B | 1,118.16% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 1,435.77% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | $0.24 B | -95.39% | 🇺🇸 USA |